Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Toward Precision Serology: Quantification of the human polyclonal antibody repertoires by proteomics and mass spectrometry
EF 2023-24
Résumé
Serological diagnostics relies on the detection of specific immunoglobulins developed against viral, bacterial, or parasitic diseases. Serological tests present simple and informative tools for clinical diagnostics and facilitate the detection of previous and current infections, and evaluation of immune status. The conventional serological tests rely on indirect immunoassays and may suffer from semi-quantitative measurements and cross-reactivity. Innovative analytical techniques such as proteomics and mass spectrometry (MS) may overcome these limitations and enable precision approaches in serology and immunology. The proposed ImmunoAffinity-Mass Spectrometry (IA-MS) will rely on the affinity enrichment of pathogen-specific polyclonal antibodies followed by their quantification by targeted MS and in-depth characterization of antibody repertoires by shotgun MS. We will focus on polyclonal antibodies against Respiratory Syncytial Virus (RSV), a contagious respiratory pathogen often manifested as a common cold infection in adults and more serious symptoms in infants and the elderly population. Anti-RSV antibodies are abundant in nearly all serum samples and provide an excellent model for development of IA-MS assays and validation of their utility in real-world applications. During this project, we will quantify by IA-MS the complete panel of human antibody isotypes and subclasses against RSV fusion glycoprotein F and attachment glycoprotein G in several hundred maternal sera samples. In addition, we will evaluate the diversity and repertoires of polyclonal antibodies. Further developments of IA-MS assays for antigen panels will provide a platform for precision serology of infectious diseases, uncover novel mechanisms of immune response, and facilitate pandemic preparedness.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506281
Name
Turner Zoe
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Toward Precision Serology: Quantification of the human polyclonal antibody repertoires by proteomics and mass spectrometry
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody Repertoire Profiling; Immunoaffinity-Mass Spectrometry; Mass Spectrometry; Proteomics; Respiratory Syncytial Virus; Serological Diagnostics
Abstract
Serological diagnostics relies on the detection of specific immunoglobulins developed against viral, bacterial, or parasitic diseases. Serological tests present simple and informative tools for clinical diagnostics and facilitate the detection of previous and current infections, and evaluation of immune status. The conventional serological tests rely on indirect immunoassays and may suffer from semi-quantitative measurements and cross-reactivity. Innovative analytical techniques such as proteomics and mass spectrometry (MS) may overcome these limitations and enable precision approaches in serology and immunology. The proposed ImmunoAffinity-Mass Spectrometry (IA-MS) will rely on the affinity enrichment of pathogen-specific polyclonal antibodies followed by their quantification by targeted MS and in-depth characterization of antibody repertoires by shotgun MS. We will focus on polyclonal antibodies against Respiratory Syncytial Virus (RSV), a contagious respiratory pathogen often manifested as a common cold infection in adults and more serious symptoms in infants and the elderly population. Anti-RSV antibodies are abundant in nearly all serum samples and provide an excellent model for development of IA-MS assays and validation of their utility in real-world applications. During this project, we will quantify by IA-MS the complete panel of human antibody isotypes and subclasses against RSV fusion glycoprotein F and attachment glycoprotein G in several hundred maternal sera samples. In addition, we will evaluate the diversity and repertoires of polyclonal antibodies. Further developments of IA-MS assays for antigen panels will provide a platform for precision serology of infectious diseases, uncover novel mechanisms of immune response, and facilitate pandemic preparedness.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Turner, Zoe
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~